Phlow Corp. applauds the Executive Order issued by the President of the United States to ensure American pharmaceutical supply chain resiliency by ...

Richmond-based pharmaceutical manufacturing company Phlow announced Tuesday that it had secured $37 million in a capital raise.

Phlow’s Series C funding coincides with several significant milestones this year, including the two newly operational U.S.-based cGMP manufacturing facilities, capable of producing APIs at both ...

Phlow and Antheia established this partnership in 2024 to leverage Antheia's biosynthesis platform for the domestic production of several key starting materials (KSMs) that support Phlow's ...

Phlow and Antheia established this partnership in 2024 to leverage Antheia's biosynthesis platform for the domestic production of several key starting materials (KSMs) that support Phlow's ...

Richmond, VA, July 22, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its ...

RICHMOND, Va., and MENLO PARK, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the ...